Skip to main content

Parallel Advisors, LLC

SEC CIK
0001690010
Latest filing
Aug 5, 2026

CORT holding history

Corcept Therapeutics Inc in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CORT overviewAll 13F holders of CORTFull Q2 2026 holdings

Shares (Q2 2026)
3,962,177
Value
$344.5M
% of portfolio
5.3%
Quarters held
22
Since Q1 2021
Holdings of CORT by Parallel Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,962,177$344.5M5.3%−15,227−0.4%ReducedHolders
Q1 20263,977,404$160.3M2.9%+98,263+2.5%AddedHolders
Q4 20253,879,141$135.0M2.5%+7,689+0.2%AddedHolders
Q3 20253,871,452$321.8M5.9%+3290.0%AddedHolders
Q2 20253,871,123$284.1M5.7%−101,293−2.5%ReducedHolders
Q1 20253,972,416$219.6M5.0%+142,784+3.7%AddedHolders
Q4 20243,829,632$193.0M4.4%+15,908+0.4%AddedHolders
Q3 20243,813,724$176.5M4.2%−2,036−0.1%ReducedHolders
Q2 20243,815,760$124.0M3.2%+830.0%AddedHolders
Q1 20243,815,677$96.1M2.6%+47,432+1.3%AddedHolders
Q4 20233,768,245$122.4M3.6%+44,762+1.2%AddedHolders
Q3 20233,723,483$101.4M3.4%−3,082−0.1%ReducedHolders
Q2 20233,726,565$82.9M2.7%+1,992+0.1%AddedHolders
Q1 20233,724,573$80.7M2.7%−910.0%ReducedHolders
Q4 20223,724,664$75.6M3.3%−44,791−1.2%ReducedHolders
Q3 20223,769,455$96.6M4.5%+1,051,127+38.7%AddedHolders
Q2 20222,718,328$64.6M3.0%+774,009+39.8%AddedHolders
Q1 20221,944,319$47.0M1.9%+140,937+7.8%AddedHolders
Q4 20211,803,382$35.7M1.3%+76,474+4.4%AddedHolders
Q3 20211,726,908$34.0M1.4%+52,551+3.1%AddedHolders
Q2 20211,674,357$36.8M1.6%+110,383+7.1%AddedHolders
Q1 20211,563,974$37.2M1.8%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.